Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro Intestinal Stromal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC 355
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Testing effectiveness (Phase 2)Study completedNCT00780494
What this trial is testing

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Who this might be right for
Stomach CancerGastric (Stomach) CancerNeoplasm of Cardioesophageal Junction+1 more
Stanford University 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087263
What this trial is testing

Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.

Who this might be right for
Gastrointestinal Stromal Tumors
M.D. Anderson Cancer Center 3
Not applicableLooking for participantsNCT07522762
What this trial is testing

Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)
The Netherlands Cancer Institute 330
Early research (Phase 1)Study completedNCT00069940
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00103168
What this trial is testing

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 908
Not applicableLooking for participantsNCT05464875
What this trial is testing

Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal TumorsUnresectable Solid TumorRecurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD 74
Testing effectiveness (Phase 2)Study completedNCT01275222
What this trial is testing

Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 117
Post-approval studies (Phase 4)Ended earlyNCT00461929
What this trial is testing

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Cell TumorsChromosome Abnormality
University Health Network, Toronto 68
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Not applicableEnded earlyNCT01054911
What this trial is testing

Evaluation of Patients With Bulky GIST Using Sunitinib

Who this might be right for
Tumor
University of Alabama at Birmingham 5
Not applicableStudy completedNCT03963544
What this trial is testing

Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)

Who this might be right for
Gastro Intestinal Stromal Tumor
Institut Bergonié 492
Large-scale testing (Phase 3)Study completedNCT02103322
What this trial is testing

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
Amneal Pharmaceuticals, LLC 48
Large-scale testing (Phase 3)Ended earlyNCT00324987
What this trial is testing

Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Not applicableUnknownNCT02931981
What this trial is testing

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
RenJi Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00940563
What this trial is testing

A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors

Who this might be right for
Advanced Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 135
Testing effectiveness (Phase 2)Study completedNCT00633295
What this trial is testing

Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor

Who this might be right for
Gastrointestinal Stromal Tumors (GIST)
Novartis Pharmaceuticals 9
Not applicableStudy completedNCT07454967
What this trial is testing

Development of a Multimodal AI System for GIST Management

Who this might be right for
Gastrointestinal Stromal TumorsGastric Subepithelial TumorsGastric Leiomyoma+2 more
Qun Zhao 300
Next Page